Breast MRI screening finds undetected cancers in 11 per 1,000 average-risk womenDecember 18, 2013OncologyWomen's HealthBreast Cancer
Add-on agents boost neoadjuvant chemo response in triple-negative diseaseDecember 17, 2013Breast CancerOncology
Meeting attendees identify top studies presented at SABCSDecember 16, 2013Breast CancerOncologyWomen's Health
Veliparib-carboplatin combo is first 'graduate' of I-SPY2 trialDecember 16, 2013Breast CancerOncologyWomen's Health
New mega-review underscores mammography’s benefitsDecember 16, 2013OncologyWomen's HealthBreast CancerPreventive Care
No survival benefit to bisphosphonate in chemoresistant breast cancerDecember 16, 2013OncologyRheumatologyWomen's HealthMusculoskeletal DisordersBreast CancerEndocrinology
Exercise dampens aromatase inhibitor–related joint painDecember 13, 2013Breast CancerOncologyWomen's HealthRheumatologyPain
SABCS Roundtable with Dr. Howard Burris and Dr. William GradisharDecember 13, 2013OncologyWomen's HealthBreast Cancer
Surgery adds little after successful chemo in metastatic breast cancerDecember 13, 2013OncologyWomen's HealthBreast Cancer
No gain seen from adjuvant bevacizumab in HER2-positive diseaseDecember 13, 2013OncologyBreast Cancer
IBIS-II: Anastrozole highly effective in preventing breast cancerDecember 13, 2013OncologyWomen's HealthBreast CancerPreventive Care
Dasatinib gives letrozole a boost in HR-positive advanced breast cancerDecember 12, 2013Breast CancerOncologyWomen's Health
VIDEO: Tumor-infiltrating lymphocytes may predict trastuzumab successDecember 12, 2013Women's HealthOncologyBreast Cancer
